1. Home
  2. Stocks
  3. Aristo Share Price

Aristo Bio-Tech and Lifescience Share Price

Agro-Chemicals Small Cap

₹147.75 +3.8 (2.64%)

05 Nov, 2024 22:06

SIP TrendupStart SIP in ARISTO

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹144
  • High
  • ₹149
  • 52 Week Low
  • ₹53
  • 52 Week High
  • ₹150
  • Open Price₹144
  • Previous Close₹144
  • Volume8,000

Investment Returns

  • Over 1 Month + 27.37%
  • Over 3 Month + 54.31%
  • Over 6 Month + 84.69%
  • Over 1 Year + 75.68%
SIP Lightning

Smart Investing Starts Here Start SIP with Aristo Bio-Tech and Lifescience for Steady Growth!

Aristo Bio-Tech and Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • PEG Ratio
  • Market Cap Cr
  • 101
  • P/B Ratio
  • 3
  • Average True Range
  • 9.7
  • EPS
  • 5.7
  • Dividend Yield
  • 0
  • MACD Signal
  • 6.82
  • RSI
  • 73.28
  • MFI
  • 84.93

Aristo Bio-Tech and Lifescience Financial

IndicatorMar 24Mar 23
Revenue From Operations [Gross]245.15217.86
Revenue From Operations [Net]245.15217.86
Total Operating Revenues245.15217.86
Total Revenue245.33218.18
Total Expenses239.92213.44
Profit/Loss Before Tax5.414.74
Profit/Loss For The Period3.903.56
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity7.60-2.78
Net Cash Used In Investing Activity-6.61-3.75
Net Cash Used in Finance Activity-2.217.97
Net Inc/Dec In Cash And Equivalent-1.221.44
Cash And Equivalent End Of Year0.641.85
IndicatorMar 24Mar 23
Total Share Capital6.816.81
Total Non-Current Liabilities10.1110.19
Total Current Liabilities83.5759.49
Total Capital And Liabilities127.2999.83
Total Non-Current Assets22.2616.72
Total Current Assets105.0383.10
Total Assets127.2999.83
Indicator20242023
EBIT Margin (%)2.893.43
Return On Capital Employed (%)16.2418.57
Return On Equity (%)11.5911.81
Long Term Debt To Equity (%)29.7433.71
Book Value/Share (INR)49.3744.30
Indicator20242023
EBIT Margin (%)2.893.43
Return On Capital Employed (%)16.2418.57
Return On Equity (%)11.5911.81
Long Term Debt To Equity (%)29.7433.71
Book Value/Share (INR)49.3744.30

Aristo Bio-Tech and Lifescience Technicals

EMA & SMA

Current Price
₹147.75
+ 3.8 (2.64%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹130.90
  • 50 Day
  • ₹119.07
  • 100 Day
  • ₹108.14
  • 200 Day
  • ₹96.21

Resistance and Support

146.92 Pivot Speed
  • R3 154.83
  • R2 151.92
  • R1 149.83
  • S1 144.83
  • S2 141.92
  • S3 139.83

Is Aristo Bio-Tech and Lifescience Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Aristo Bio-Tech And Lifescience has an operating revenue of Rs. 796.21 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 2% needs improvement, ROE of 11% is good. The company has a reasonable debt to equity of 30%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 25% and 60% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 24% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 86 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 42 indicates it belongs to a fair industry group of Chemicals-Agricultural and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Aristo Bio-Tech and Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-05-27 Audited Results & Dividend
2023-11-07 Quarterly Results
2023-05-27 Audited Results & Dividend
Date Purpose Remarks
2023-09-15 FINAL Recommended Final Dividend of 0.25 per equity share

Aristo Bio-Tech and Lifescience F&O

Aristo Bio-Tech and Lifescience Shareholding Pattern

73.37%
23.69%
2.94%
  • NSE Symbol
  • ARISTO
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Narendra Singh Barhat
  • ISIN
  • INE082101010

Aristo Bio-Tech and Lifescience FAQs

Aristo Bio-Tech and Lifescience share price is ₹147 As on 05 November, 2024 | 21:52

The Market Cap of Aristo Bio-Tech and Lifescience is ₹100.6 Cr As on 05 November, 2024 | 21:52

The P/E ratio of Aristo Bio-Tech and Lifescience is As on 05 November, 2024 | 21:52

The PB ratio of Aristo Bio-Tech and Lifescience is 3 As on 05 November, 2024 | 21:52

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.